Translate Bio, Inc. Recorded Big Gain
Fri, Aug 02, 2024 at 07:08 PM
Translate Bio, Inc. (TBIO:NASDAQ) shot up at $5.5, a gain of 30.3%. On Fri, Aug 02, 2024, TBIO:NASDAQ hit a New 2-Week High of $5.5. From Fri, Jul 19, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Fri, Feb 23, 2024 at $15.46 with a volume of 1M+.
About Translate Bio, Inc. (TBIO:NASDAQ)
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.
Top 10 Gainers:
- VSee Health Inc Com (VSEE:NASDAQ), 74.9%
- OS Therapies Incorporated (OSTX:NYSEMKT), 59.36%
- MKDWELL Tech Inc. (MKDW:NASDAQ), 54.81%
- Shimmick Corporation (SHIM:NASDAQ), 49.24%
- Translate Bio, Inc. (TBIO:NASDAQ), 30.33%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 29.84%
- TOYO Co. Ltd (TOYO:NASDAQ), 27.15%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 24%
- MOGU Inc. (MOGU:NYSE), 23.95%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 23.93%